Muscoridol (Diclofenac Epolamine)

Diclofenac epolamine, the active ingredient in Muscoridol, is a nonsteroidal anti‑inflammatory drug presented as a topical formulation for skin application. It is used to relieve mild to moderate musculoskeletal pain, reduce localized inflammation, and manage osteoarthritis‑related joint discomfort in adults.

GNH USA supplies Muscoridol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Muscoridol, a topical NSAID, acts on inflammatory pathways that contribute to musculoskeletal disorders. - Musculoskeletal pain: provides localized analgesia and reduces inflammation in strained muscles and joints. - Soft‑tissue injury: diminishes swelling and discomfort in bruises, sprains and tendonitis. - Osteoarthritis: alleviates joint pain and stiffness associated with degenerative cartilage loss.

Topical diclofenac may cause local and systemic adverse reactions.

Common Side Effects: - Skin irritation: mild burning or stinging at the application site. - Redness: localized erythema. - Itching: pruritus around the treated area. - Dryness: flaky or dry skin. - Rash: mild maculopapular eruption. - Peeling: desquamation of superficial skin layers.

Serious or Rare Side Effects: - Allergic reaction: angio‑edema, urticaria, or anaphylaxis. - Severe skin disorders: Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Necrotizing skin lesions: localized skin necrosis. - Systemic NSAID toxicity: gastrointestinal ulceration or bleeding. - Hepatic injury: elevated liver enzymes or hepatitis. - Renal impairment: reduced kidney function or acute renal failure.

Before using Muscoridol, consider the following safety measures. - Cardiovascular risk assessment: avoid in patients with uncontrolled hypertension or recent cardiovascular events. - Gastro‑intestinal history: use cautiously in individuals with a history of ulcers or bleeding. - Renal/hepatic function: evaluate kidney and liver status, especially in chronic disease. - Skin integrity: do not apply to infected, broken, or ulcerated skin. - Concomitant NSAIDs: avoid using other topical or systemic NSAIDs simultaneously. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Diclofenac epolamine may interact with systemic medicines that affect bleeding, renal function, or electrolyte balance.

Major Interactions (Avoid): - Oral anticoagulants (e.g., warfarin): increased risk of bleeding. - Systemic NSAIDs: additive gastrointestinal and renal toxicity. - Lithium: elevated lithium serum levels. - Methotrexate: reduced clearance leading to toxicity. - ACE inhibitors/ARBs: potential for reduced renal perfusion.

Moderate Interactions (Monitor Closely): - Diuretics: possible decline in renal function. - Corticosteroids: heightened risk of skin ulceration. - SSRIs or SNRIs: modest increase in bleeding tendency. - Antihypertensives: may blunt antihypertensive effect.